Rizvi Syed Ali-aamir

Rizvi Syed Ali-aamir is listed in filings as Chief Medical Officer at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including 7 public disclosures. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT) and Poseida Therapeutics, Inc. (PSTX). The current snapshot covers public activity from Jan 8, 2025 to Feb 13, 2026. Reported amounts are shown as $301.4K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.